CLINICAL_TRIALS
trial_result
· 2020-01-02
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Radion™-Pdt in Patients With Oral Precancerous Lesion [Phase 2]
Summary
A Phase 2 trial evaluating the efficacy and safety of Radion™-Pdt in oral precancerous lesions (erythroleukoplakia and verrucous hyperplasia) has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pharma Power Biotec Co., Ltd. | Conditions: Erythroleukoplakia of Mouth, Verrucous Hyperplasia of Oral Mucosa | Phase 2 | Status: COMPLETED